LifeVantage reaffirms FY26 EPS outlook $1.00-$1.15, consensus $1.01

Sees FY26 revenue $225M-$240M. Sees FY26 adjusted EBITDA $23M-$26M. The company continues to anticipate revenue in the second half of the fiscal year will be higher than the first half due to the seasonality associated with its MindBody product line and the impact of the LoveBiome acquisition. The company expects a full year tax rate of approximately 24% to 26%. This guidance reflects the current trends in the business. The company’s guidance for adjusted non-GAAP EBITDA and adjusted non-GAAP earnings per diluted share excludes any non-operating or non-recurring expenses that may materialize during fiscal 2026.